{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T02:56:53Z","timestamp":1793501813378,"version":"4.5.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82104090"],"award-info":[{"award-number":["82104090"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2025A1515010594"],"award-info":[{"award-number":["2025A1515010594"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007162","name":"Guangdong Provincial Department of Science and Technology","doi-asserted-by":"publisher","award":["2019B090904008"],"award-info":[{"award-number":["2019B090904008"]}],"id":[{"id":"10.13039\/501100007162","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2025YFE0107400"],"award-info":[{"award-number":["2025YFE0107400"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jconrel.2026.114655","type":"journal-article","created":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T17:01:14Z","timestamp":1769101274000},"page":"114655","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Inhalable stealth liposomes improve peptide delivery for pulmonary fibrosis treatment"],"prefix":"10.1016","volume":"391","author":[{"given":"Ruibo","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengqing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuelan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhao","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongfang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yugen","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoqun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiabin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongzhuo","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2026.114655_bb0005","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1056\/NEJMra2005230","article-title":"Spectrum of fibrotic lung diseases","volume":"383","author":"Wijsenbeek","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2026.114655_bb0010","doi-asserted-by":"crossref","first-page":"2103187","DOI":"10.1183\/13993003.03187-2021","article-title":"Progressive pulmonary fibrosis: an expert group consensus statement","volume":"61","author":"Rajan","year":"2023","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.jconrel.2026.114655_bb0015","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.molmed.2023.08.010","article-title":"Pulmonary fibrosis: from pathogenesis to clinical decision-making","volume":"29","author":"Koudstaal","year":"2023","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.jconrel.2026.114655_bb0020","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev.med.55.091902.103810","article-title":"Mechanisms of pulmonary fibrosis","volume":"55","author":"Thannickal","year":"2004","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.jconrel.2026.114655_bb0025","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1146\/annurev-pathol-042320-030240","article-title":"Pathogenic mechanisms underlying idiopathic pulmonary fibrosis","volume":"17","author":"Moss","year":"2022","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.jconrel.2026.114655_bb0030","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0154-2020","article-title":"Health-related quality of life of patients with idiopathic pulmonary fibrosis: a systematic review and meta-analysis","volume":"29","author":"Cox","year":"2020","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.jconrel.2026.114655_bb0035","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1056\/NEJMra1705751","article-title":"Idiopathic pulmonary fibrosis","volume":"378","author":"Lederer","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2026.114655_bb0040","doi-asserted-by":"crossref","first-page":"2401305","DOI":"10.1183\/13993003.01305-2024","article-title":"Idiopathic pulmonary fibrosis mortality: update on trends in the modern treatment era","volume":"64","author":"Podolanczuk","year":"2024","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.jconrel.2026.114655_bb0045","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1007\/s12325-025-03215-6","article-title":"Progressive pulmonary fibrosis: current status in terminology and future directions","volume":"42","author":"Kondoh","year":"2025","journal-title":"Adv. Ther."},{"key":"10.1016\/j.jconrel.2026.114655_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107070","article-title":"MMP14high macrophages orchestrate progressive pulmonary fibrosis in SR-ag-induced hypersensitivity pneumonitis","volume":"200","author":"Peng","year":"2024","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.jconrel.2026.114655_bb0055","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1001\/jamainternmed.2023.3295","article-title":"Silicosis among immigrant engineered stone (quartz) countertop fabrication workers in California","volume":"183","author":"Fazio","year":"2023","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.jconrel.2026.114655_bb0060","doi-asserted-by":"crossref","first-page":"2101739","DOI":"10.1183\/13993003.01739-2021","article-title":"The role of cigarette smoking-derived pollutants in the risk of mortality in idiopathic pulmonary fibrosis","volume":"58","author":"Yoon","year":"2021","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.jconrel.2026.114655_bb0065","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/17476348.2024.2329612","article-title":"Drug-induced interstitial lung disease: a narrative review of a clinical conundrum","volume":"18","author":"Harrison","year":"2024","journal-title":"Expert Rev. Respir. Med."},{"key":"10.1016\/j.jconrel.2026.114655_bb0070","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S2213-2600(22)00259-4","article-title":"Lung epithelial and myeloid innate immunity in influenza-associated or COVID-19-associated pulmonary aspergillosis: an observational study","volume":"10","author":"Feys","year":"2022","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.jconrel.2026.114655_bb0075","doi-asserted-by":"crossref","DOI":"10.1136\/bmjmed-2024-000911","article-title":"Progressive pulmonary fibrosis: a need for real world data to solve real world clinical problems","volume":"3","author":"Liu","year":"2024","journal-title":"BMJ Med."},{"key":"10.1016\/j.jconrel.2026.114655_bb0080","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1186\/s12890-025-03836-1","article-title":"Incidence and prevalence of idiopathic pulmonary fibrosis: a systematic literature review and meta-analysis","volume":"2","author":"Golchin","year":"2025","journal-title":"BMC Pulm. Med."},{"key":"10.1016\/j.jconrel.2026.114655_bb0085","doi-asserted-by":"crossref","first-page":"2300752","DOI":"10.1183\/13993003.00752-2023","article-title":"Effects of nintedanib on symptoms in patients with progressive pulmonary fibrosis","volume":"63","author":"Wijsenbeek","year":"2024","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.jconrel.2026.114655_bb0090","doi-asserted-by":"crossref","first-page":"2300240","DOI":"10.1183\/13993003.00240-2023","article-title":"Another piece in the pirfenidone puzzle","volume":"61","author":"Lehmann","year":"2023","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.jconrel.2026.114655_bb0095","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.7150\/ijbs.92620","article-title":"Nintedanib mitigates radiation-induced pulmonary fibrosis by suppressing epithelial cell inflammatory response and inhibiting fibroblast-to-myofibroblast transition","volume":"20","author":"Tu","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.jconrel.2026.114655_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2022.114066","article-title":"Pirfenidone ameliorates pulmonary inflammation and fibrosis in a rat silicosis model by inhibiting macrophage polarization and JAK2\/STAT3 signaling pathways","volume":"244","author":"Tang","year":"2022","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"10.1016\/j.jconrel.2026.114655_bb0105","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1007\/s12325-019-00906-9","article-title":"Long-term effects and adverse events of nintedanib therapy in idiopathic pulmonary fibrosis patients with functionally advanced disease","volume":"36","author":"Barczi","year":"2019","journal-title":"Adv. Ther."},{"key":"10.1016\/j.jconrel.2026.114655_bb0110","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S2213-2600(20)30330-1","article-title":"Efficacy and safety of nintedanib in patients with systemic sclerosis-associated interstitial lung disease treated with mycophenolate: a subgroup analysis of the SENSCIS trial","volume":"9","author":"Highland","year":"2021","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.jconrel.2026.114655_bb0115","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0057-2017","article-title":"Pirfenidone safety and adverse event management in idiopathic pulmonary fibrosis","volume":"26","author":"Lancaster","year":"2017","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.jconrel.2026.114655_bb0120","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S2213-2600(18)30502-2","article-title":"Lung transplantation for idiopathic pulmonary fibrosis","volume":"7","author":"George","year":"2019","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.jconrel.2026.114655_bb0125","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.athoracsur.2023.09.038","article-title":"Outcomes of lung transplantation for idiopathic pulmonary fibrosis: glass half full or still half empty?","volume":"117","author":"Bromberger","year":"2024","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.jconrel.2026.114655_bb0130","doi-asserted-by":"crossref","first-page":"2200957","DOI":"10.1183\/13993003.00957-2022","article-title":"Idiopathic pulmonary fibrosis: state of the art for 2023","volume":"61","author":"Podolanczuk","year":"2023","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.jconrel.2026.114655_bb0135","doi-asserted-by":"crossref","first-page":"3748","DOI":"10.1038\/s41467-025-59093-7","article-title":"Targeted immunotherapy rescues pulmonary fibrosis by reducing activated fibroblasts and regulating alveolar cell profile","volume":"16","author":"Yan","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.114655_bb0140","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1164\/rccm.202401-0238SO","article-title":"Genetics and genomics of pulmonary fibrosis: charting the molecular landscape and shaping precision medicine","volume":"210","author":"Adegunsoye","year":"2024","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jconrel.2026.114655_bb0145","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1080\/03639045.2017.1371736","article-title":"Formulation for a novel inhaled peptide therapeutic for idiopathic pulmonary fibrosis","volume":"44","author":"Surasarang","year":"2018","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.jconrel.2026.114655_bb0150","doi-asserted-by":"crossref","first-page":"eaat2848","DOI":"10.1126\/scitranslmed.aat2848","article-title":"Caveolin-1-derived peptide limits development of pulmonary fibrosis","volume":"11","author":"Marudamuthu","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2026.114655_bb0155","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.137969","article-title":"Caveolin-1 scaffolding domain peptide regulates glucose metabolism in lung fibrosis","volume":"5","author":"Gopu","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.jconrel.2026.114655_bb0160","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1016\/j.ajpath.2018.07.005","article-title":"p53 expression in lung fibroblasts is linked to mitigation of fibrotic lung remodeling","volume":"188","author":"Nagaraja","year":"2018","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jconrel.2026.114655_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.104022","article-title":"Caveolin-1 peptide regulates p53-microRNA-34a feedback in fibrotic lung fibroblasts","volume":"25","author":"Hogan","year":"2022","journal-title":"iScience"},{"key":"10.1016\/j.jconrel.2026.114655_bb0170","doi-asserted-by":"crossref","first-page":"554","DOI":"10.3390\/cells12040554","article-title":"Caveolin-1-related intervention for fibrotic lung diseases","volume":"12","author":"Shetty","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.jconrel.2026.114655_bb0175","first-page":"632","article-title":"Development of an excipient-free peptide dry powder inhalation for the treatment of pulmonary fibrosis","volume":"17","author":"Zhang","year":"2020","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2026.114655_bb0180","article-title":"Pre-clinical proof-of-concept of anti-fibrotic activity of caveolin-1 scaffolding domain peptide LTI-03 in ex vivo precision cut lung slices from patients with idiopathic pulmonary fibrosis","author":"MacKenzie","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.jconrel.2026.114655_bb0185","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1164\/ajrccm.149.5.8173769","article-title":"Effects of pulmonary fibrosis on the distribution of edema computed tomographic scanning and morphology","volume":"149","author":"Zwikler","year":"1994","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jconrel.2026.114655_bb0190","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1016\/j.jacc.2019.02.074","article-title":"Osteopontin promotes left ventricular diastolic dysfunction through a mitochondrial pathway","volume":"73","author":"Yousefi","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.jconrel.2026.114655_bb0195","doi-asserted-by":"crossref","first-page":"eadj9559","DOI":"10.1126\/sciadv.adj9559","article-title":"Modeling mechanical activation of macrophages during pulmonary fibrogenesis for targeted anti-fibrosis therapy","volume":"10","author":"Xu","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2026.114655_bb0200","first-page":"262","article-title":"Alveolar macrophage phagocytosis-evading inhaled microgels incorporating nintedanib-PLGA nanoparticles and pirfenidone-liposomes for improved treatment of pulmonary fibrosis","volume":"33","author":"Lee","year":"2024","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.jconrel.2026.114655_bb0205","doi-asserted-by":"crossref","first-page":"eado4791","DOI":"10.1126\/sciadv.ado4791","article-title":"Realveolarization with inhalable mucus-penetrating lipid nanoparticles for the treatment of pulmonary fibrosis in mice","volume":"10","author":"Wang","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2026.114655_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.130839","article-title":"Polysaccharides screening for pulmonary mucus penetration by molecular dynamics simulation and in vitro verification","volume":"265","author":"Peng","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jconrel.2026.114655_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.115147","article-title":"Emerging delivery approaches for targeted pulmonary fibrosis treatment","volume":"204","author":"Diwan","year":"2024","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.114655_bb0220","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jconrel.2022.05.039","article-title":"Novel drug delivery systems and disease models for pulmonary fibrosis","volume":"348","author":"Li","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114655_bb0225","first-page":"324","article-title":"Enhanced peptide delivery and sustainable release of pleurocidin using N-succinyl chitosan nanoparticle, Nano","volume":"9","author":"Bupesh","year":"2017","journal-title":"Biomed. Eng."},{"key":"10.1016\/j.jconrel.2026.114655_bb0230","doi-asserted-by":"crossref","first-page":"eadg5358","DOI":"10.1126\/sciadv.adg5358","article-title":"Nanoengineered mesenchymal stem cell therapy for pulmonary fibrosis in young and aged mice","volume":"9","author":"Han","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2026.114655_bb0235","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1038\/s41467-020-14344-7","article-title":"Inhalation of lung spheroid cell secretome and exosomes promotes lung repair in pulmonary fibrosis","volume":"11","author":"Dinh","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.114655_bb0240","doi-asserted-by":"crossref","first-page":"9471","DOI":"10.1038\/s41467-024-53914-x","article-title":"Charge-assisted stabilization of lipid nanoparticles enables inhaled mRNA delivery for mucosal vaccination","volume":"15","author":"Liu","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.114655_bb0245","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.1016\/j.scib.2023.11.004","article-title":"Polymyxin B sulfate inhalable microparticles with high-lectin-affinity sugar carriers for efficient treatment of biofilm-associated pulmonary infections","volume":"68","author":"Zhou","year":"2023","journal-title":"Sci. Bull."},{"key":"10.1016\/j.jconrel.2026.114655_bb0250","article-title":"Pulmonary-targeted nanoparticles interrupt the malignant mechanical and biochemical signaling crosstalk for idiopathic pulmonary fibrosis therapy","author":"Li","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2026.114655_bb0255","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.jconrel.2024.01.032","article-title":"Inhaled nanoparticles for treating idiopathic pulmonary fibrosis by inhibiting honeycomb cyst and alveoli interstitium remodeling","volume":"366","author":"Han","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114655_bb0260","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1056\/NEJMoa2310307","article-title":"Inhaled amikacin to prevent ventilator-associated pneumonia","volume":"389","author":"Ehrmann","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2026.114655_bb0265","article-title":"Inhalable hsa-miR-30a-3p liposomes attenuate pulmonary fibrosis","volume":"12","author":"Liu","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2026.114655_bb0270","doi-asserted-by":"crossref","first-page":"2100864","DOI":"10.1183\/13993003.00864-2021","article-title":"Intracellular hydroxyproline imprinting following resolution of bleomycin-induced pulmonary fibrosis","volume":"59","author":"Song","year":"2022","journal-title":"Eur. Respir. J."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926000568?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926000568?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T08:34:20Z","timestamp":1781771660000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365926000568"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":54,"alternative-id":["S0168365926000568"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.114655","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhalable stealth liposomes improve peptide delivery for pulmonary fibrosis treatment","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.114655","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"114655"}}